Powering innovation and progress in genomics and precision medicine

Special Interest Groups (SIGs) are carefully curated, invite-only gatherings of senior and technical experts from academia, healthcare, pharma, diagnostics  and technology companies. Participants share expertise, discuss business/research-critical business challenges, and work towards actionable, robust solutions and best practices for both attendees and the wider community. 

The meetings are organised by Front Line Genomics, and discussion points, solutions and suggestions are reported both through our website and via intelligence reports that are shared with the wider community. These are not silos. The whole community benefits.

There are two types of SIGs:

  • Special Interest Groups (SIGs) are half-day meetings of 15-20 experienced technical, research and/or business people, focused on a business or research -critical topic area. The first SIGs took place in London in January and in March in Boston, to excellent feedback. The next 5 SIGs take place in Boston on June 19/20/21. Learn More →
  • The Big SIG is a one-day meeting of 120-150 people, all focused on a broad topic, but breaking down into themed discussion tables, with presentations and ample networking time, as part of a larger meeting. The next Big SIG takes place in Boston on September 12th, and is currently in development. Learn More →
...A perfect opportunity to engage in a pre-competitive discussion and affirm (and identify) high priority challenges. The SIGs helped us to validate solutions with industry experts in a transparent way.
— Vibhor Gupta, Director, Pangaea Group

Who attends?

SIG meetings attract the best and brightest from across the personalised medicine/genomics sector. Here are just some of the organisations represented so far: 

upcoming meetings

The next 6 half-day SIG meetings are already being organised, and take place in Boston, MA, on June 19/20/21st. 

Learn More →

partner with us

Have something to contribute? Find out how to use SIG meetings to influence decision makers and improve your own proposition.

Find Out How →